newsfilter
← Latest News
ACCESS Newswire·

CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK

Phase 1 part of combined Phase 1/2 study initiated as part of pandemic preparedness against highly pathogenic avian influenza virus, considered to be potential future pandemic threatStudy will assess monovalent